Clover Health Shares Surge on Positive 2027 Medicare Advantage Star Ratings

Key Facts

1Clover Health Investments shares jumped after CMS awarded the company's Medicare Advantage plans high 2027 Star ratings.

Clover Health Investments shares jumped after CMS awarded the company's Medicare Advantage plans high 2027 Star ratings. Benzinga reported that these ratings are a critical fundamental driver for providers, as they often lead to increased bonus payments and better marketing positioning.

CLOV closed at $4.58 on October 8, 2026, with the stock reaching a day high of $4.6 and a low of $4.44. The upward movement reflects investor optimism regarding the impact of the CMS ratings on the company's future revenue and long-term profitability.